A Single-arm, open-label, Phase II study of sabatolimab in combination with azacitidine and venetoclax in adult participants with high or very high risk myelodysplastic syndrome (MDS) as per IPSS-R criteria

  • Tiong, Ing Soo (Primary Chief Investigator (PCI))
  • Kennedy, Nola (Project Manager)

Project: Research

Project Details

Effective start/end date28/05/2131/12/23


  • Myelodysplastic syndrome
  • Haematology
  • Clinical trial